Repository logo
 

Study profile: the Durban Diabetes Study (DDS): a platform for chronic disease research.

Published version
Peer-reviewed

Repository DOI


Type

Article

Change log

Authors

Hird, TR 
Young, EH 
Pirie, FJ 
Riha, J 
Esterhuizen, TM 

Abstract

The Durban Diabetes Study (DDS) is a population-based cross-sectional survey of an urban black population in the eThekwini Municipality (city of Durban) in South Africa. The survey combines health, lifestyle and socioeconomic questionnaire data with standardised biophysical measurements, biomarkers for non-communicable and infectious diseases, and genetic data. Data collection for the study is currently underway and the target sample size is 10 000 participants. The DDS has an established infrastructure for survey fieldwork, data collection and management, sample processing and storage, managed data sharing and consent for re-approaching participants, which can be utilised for further research studies. As such, the DDS represents a rich platform for investigating the distribution, interrelation and aetiology of chronic diseases and their risk factors, which is critical for developing health care policies for disease management and prevention. For data access enquiries please contact the African Partnership for Chronic Disease Research (APCDR) at data@apcdr.org or the corresponding author.

Description

Keywords

Chronic disease, epidemiology, genetics, population-based, study profile

Journal Title

Glob Health Epidemiol Genom

Conference Name

Journal ISSN

2054-4200
2054-4200

Volume Title

1

Publisher

Hindawi Limited
Sponsorship
Medical Research Council (MR/K013491/1)
The study was supported by the Wellcome Trust (grant number 098051), the African Partnership for Chronic Disease Research (Medical Research Council UK partnership grant number MR/K013491/1), the National Institute for Health Research Cambridge Biomedical Research Centre (UK), the Gates Cambridge Scholarship programme (UK), Novo-Nordisk (South Africa), Sanofi-Aventis (South Africa), and MSD Pharmaceuticals (Pty) Ltd (Southern Africa).